Abstract
Radioiodinated monoclonal antibodies (MCA) were administered by the lumbar route into the cerebrospinal fluid (CSF) of four patients with malignant leptomeningeal disease. Evidence suggesting uptake of131I-MCA by tumour sites was seen in scintigrams. Dosimetry calculations were carried out, assuming that a proportion of the administered radionuclide was bound as a thin layer on the CSF surfaces of the meninges. The percentage injected dose and the clearance curves for the head and four spinal segments were obtained by scintigraphy after administration of tracer amounts of131I-MCA (7–18 MBq). Although radioisotope levels in the central nervous system (CNS) fell, as determined by both external scintillation counting and direct CSF sampling, a marked difference in the measurements developed with respect to time. The ratio of these two measurements reached a maximum of 49:1, 7 days after monoclonal antibody administration. Patients subsequently received therapeutic amounts (870–1600 MBq) of131I-MCAs, resulting in clinical remissions and prolonged survival. The mean absorbed radiation dose was estimated as 3.9 cGy·MBq−1 to the thoraco-lumbar region of the spine and 0.51 cGy·MBq−1 to the outer surface of the brain. The maximal dose delivered to the surface of the CNS in the region of the spine and brain was 5800 and 600 cGy, respectively.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bourne S, Lashford LS, Garson J, Coakham HB, Kemshead JT (1989) Monoclonal antibodies M340 and UJ181.4 recognize antigens associated with primitive neuroectodermal tumours/tissues. Hybridoma 8:415–426
Brown IH, Lee TJ, Eden OB, Bullimore JA, Savage DCL (1983) Growth and endocrine function after treatment for medulloblastoma. Arch Dis Child 58:722–727
Buchegger F, Mach JP, Leonnard P, Carrel BS, Carrel S (1986) Selective tumour localisation of radiolabelled anti-human melanoma monoclonal antibody fragment demonstrated in the nude mouse model. Cancer 58:655–662
Chin HW, Maruyama Y (1983) Recent progress and results of modern radiation therapy in medulloblastoma. Prog Clin Biol Res 130:401–410
Coakham HB, Richardson RB, Davies AG, Bourne SP, Eckert H, Kemshead JT (1988) Neoplastic meningitis from a pineal tumour treated by antibody guided irradiation via the intrathecal route. Br J Neurosurgery 2:199–209
Dalchau R, Fabre JW (1981) Identification with a monoclonal antibody of a predominantly B lymphocyte-specific determinant of the human leukocyte common antigen. J Exp Med 153:753–765
D'Angio GJ, Littman P, Nesbit M, Sather H, Hittle R, Ortega J, Donaldson M, Hammond D (1981) Evaluation of radiation therapy factors in prophylactic central nervous system irradiation for childhood leukaemia: a report from the children's cancer study group. Int J Radiat Oncol Biol Phys 7:1031–1038
DiChiro O, Fisher RL (1964) Contrast radiography of the spinal cord. Arch Neurol 2:125–143
Doges H, Hliscs R (1984) Intrathecal therapy with198Au-colloid for meningosis prophlaxis. Eur J Nucl Med 9:125–128
Hammersmith Oncology Group and Imperial Cancer Research Fund (1984) Antibody-guided irradiation of malignant lesions: three cases illustrating a new method of treatment. Lancet i:1441–1443
Hammond ND, Moldofsky PJ, Beardsley MR, Mulhern CB (1984) External imaging techniques for quantitation of distribution of I-131 F(ab')2 fragments of monoclonal antibody in humans. Med Phys 11(6):778–783
Harbert JC, McCullogh DC, Zeiger LS, Davidson JD (1970) Cisternography. J Nucl Med 11:534–541
Hilditch TE (1968) Radiation dose in isotope encephalography. Lancet ii:573–574
Hunter WM, Greenwood FC (1962) Preparation of iodine-131 labelled growth hormone of high specific activity. Nature 194:495–496
Hustu HO, Aur RJA, Verzosa MS, Simone JV, Pinkel D (1973) Prevention of central nervous system leukaemia by irradiation. Cancer 32:585–597
Jones DH, Goldman A, Gordon I, Pritchard J, Gregory BJ, Kemshead JT (1985) Therapeutic application of radiolabelled monoclonal UJ13A in nude mice xenografted with human neuroblastoma: tumouricidal effects and distribution studies. Int J Cancer 35:715–720
Lashford LS, Jones D, Pritchard J, Gordon I, Breatnach F, Kemshead JT (1987) Therapeutic application of radiolabelled monoclonal antibody UJ13A in children with disseminated neuroblastoma. Natl Cancer Inst Monogr 3:53–57
Lashford LS, Davies AG, Richardson RB, Bullimore JA, Eckert H, Kemshead JT, Coakham HB (1988) A pilot study of131I monoclonal antibodies in the therapy of leptomeningeal tumour. Cancer 61:857–868
Loevinger R, Japha EM, Brownell GL (1956) Discrete radioisotope sources. In: Hine GJ, Brownell GL (Eds) Radiation dosimetry. Academic Press, New York 693–799
Richardson RB, Davies AG, Bourne SP, Staddon GE, Jones DH, Kemshead JT, Coakham HB (1986) Radioimmunolocalisation of human brain tumours: Biodistribution of radiolabelled monoclonal antibody UJ13A. Eur J Nucl Med 12:313–320
Silverman CL Palkes H, Talent B, Kovnar E, Clouse JW, Thomas PRM (1984) Late effects of radiotherapy on patients with cerebellar medulloblastoma. Cancer 54:825–829
Snyder WS, Ford MR, Warner GC, Watson SB (1975) “S” absorbed dose per unit accumulated activity for selected radionuclides and organs. Medical Internal Radiation Dose Committee, pamphlet no. 11. Soc Nucl Med, New York
Thomas SR, Maxon HR, Kerciakes JG (1976) In vivo quantitation of lesion radioactivity using external counting methods. Med Phys 3:253–255
Vaughan ATM, Anderson P, Dykes PW, Chapman CE, Bradwell AR (1987) Limitations to the killing of tumours using radiolabelled antibodies. Br J Radiol 60:567–578
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Richardson, R.B., Kemshead, J.T., Davies, A.G. et al. Dosimetry of intrathecal iodine131 monoclonal antibody in cases of neoplastic meningitis. Eur J Nucl Med 17, 42–48 (1990). https://doi.org/10.1007/BF00819403
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00819403